Kristine Ball
2017
In 2017, Kristine Ball earned a total compensation of $996.3K as Senior Vice President, Corporate Strategy and Chief Financial Officer at VYNE Therapeutics.
Compensation breakdown
| Bonus | $53,200 |
|---|---|
| Option Awards | $825,066 |
| Salary | $118,030 |
| Total | $996,296 |
Ball received $825.1K in option awards, accounting for 83% of the total pay in 2017.
Ball also received $53.2K in bonus and $118K in salary.
Rankings
In 2017, Kristine Ball's compensation ranked 8,988th out of 14,666 executives tracked by ExecPay. In other words, Ball earned more than 38.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,988 out of 14,666 | 39th |
Division Manufacturing | 3,439 out of 5,768 | 40th |
Major group Chemicals And Allied Products | 1,174 out of 2,074 | 43rd |
Industry group Drugs | 938 out of 1,730 | 46th |
Industry Pharmaceutical Preparations | 735 out of 1,329 | 45th |
Source: SEC filing on May 10, 2019.
Ball's colleagues
We found two more compensation records of executives who worked with Kristine Ball at VYNE Therapeutics in 2017.